Harnessing Artificial Intelligence for the Design and Development of Novel Effective Medicines

The high costs and frequent failures have historically hindered the progress of developing medicines, due, to inefficiencies in the drug discovery process.To revolutionize drug development, in the current study we proposed a plan based on the use of artificial intelligence (AI).Our cutting-edge AI algorithms are designed to enhance drug candidates and predict their properties by leveraging machine learning, deep learning, and natural language processing.Our comprehensive approach involves data preparation, AI model creation, virtual screenings, molecule simulations, ADME/toxicity predictions and validation through experiments.We have generated 10,000 molecules, which were then narrowed down to 500 candidates.Showcasing the remarkable capabilities of our AI driven system.With an F1 score of 0.92 for bioactivity prediction an accuracy rate of 0.88, for solubility prediction and a toxicity prediction accuracy of 0.95; our machine learning models have exhibited performance.Our deep learning models have also performed well; for example, our CNN model for solubility prediction had a remarkable mean absolute error of 0.3 log units, while our GCN model for drug-target interactions had an area under the curve of 0.98.Chemicals created by AI with high binding affinities, such -12.5 kcal/ mol, have been uncovered using molecular docking simulations.Among our notable accomplishments is the successful synthesis of twenty compounds, all of which have strong bioactivities with IC50 values between ten and two hundred nanometers.Importantly, research conducted in living organisms (mice and rats) has shown substantial therapeutic effectiveness, with outcomes such as a 60% suppression of tumor growth and a 75% decrease in inflammation.Our AI platform has proven time and time again that it can produce new, powerful drug candidates with desirable characteristics, opening the door to a more efficient drug discovery process that can hasten the distribution of revolutionary treatments and enhance patient results.